scispace - formally typeset
Open AccessJournal ArticleDOI

Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform.

Reads0
Chats0
TLDR
The results do not support a major role for regular ICS use in protecting against COVID-19-related death among people with asthma or COPD, and the apparent harmful association observed can be plausibly explained by unmeasured confounding due to disease severity.
Citations
More filters
Journal ArticleDOI

Management of COPD patients during COVID: difficulties and experiences.

TL;DR: The role of COPD in COVID-19 infection is not yet well understood as mentioned in this paper, however, there is increasing evidence showing that COPD patients with CoV-19 have a higher risk of presenting a serious infection, a greater likelihood of requiring ICU support, and a higher mortality than other groups.
Journal ArticleDOI

Inhaled β2 Adrenergic Agonists and Other cAMP-Elevating Agents: Therapeutics for Alveolar Injury and Acute Respiratory Disease Syndrome?

TL;DR: In this paper, the potential of β2-AR agonists, in particular LABAs, for the treatment of acute respiratory distress syndrome (ARDS) induced by pneumonia and focus on the pathobiology of ARDS and actions of inhaled β2 adrenergic receptors and cAMP on pulmonary and immune cell types.
Journal ArticleDOI

Mortality of COVID-19 is associated with comorbidity in patients with chronic obstructive pulmonary disease

TL;DR: In this article , the authors compared the outcome of COPD patients with the outcome in matched COVID-19 patients without COPD in hospitalised patients with chronic obstructive pulmonary disease (COPD) and showed a trend towards a higher 30-day mortality than control patients.
Journal ArticleDOI

Eight Good Reasons for Careful Monitoring and Evaluation of the Vaccine Campaign against COVID-19: Lessons Learned through the Lombardy Experience for Dealing with Next Challenges

TL;DR: The reduced effectiveness of the vaccine over time was studied and identified risk factors of post-vaccine infection and severe illness and the correct use of rapidly available observational data of good quality and completeness generates reliable evidence to inform patients and policymakers.
Journal ArticleDOI

Effect of asthma, COPD, and ACO on COVID-19: A systematic review and meta-analysis

TL;DR: In this article , a systematic review and meta-analysis was conducted to assess the prevalence of asthma, COPD, and ACO as comorbidities, and to determine their risks of mortality in patients with COVID-19 using a systematic search and meta analysis.
References
More filters
Journal ArticleDOI

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

TL;DR: Characteristics of patients who died were in line with the MuLBSTA score, an early warning model for predicting mortality in viral pneumonia, and further investigation is needed to explore the applicability of the Mu LBSTA scores in predicting the risk of mortality in 2019-nCoV infection.
Journal ArticleDOI

Global strategy on diet, physical activity and health

TL;DR: An expert report aiming to design strategies in promoting healthy diets and physical activity behaviours was published a year ago by the United Nations Food and Agriculture Organization.
Related Papers (5)
Trending Questions (1)
Is Covid fatal for people with asthma?

Interpretation Our results do not support a major role for regular ICS use in protecting against COVID-19-related death among people with asthma or COPD.